Screening, Diagnosis, and Management of Hereditary Renal Cell Carcinoma
Because of hereditary RCC’s rarity, there is an overall lack of recommendations for diagnosing and managing patients who are suspected or confirmed to have the disease. However, because some hereditary RCC syndromes may be aggressive, it is important to effectively diagnose and manage patients as early as possible to limit associated morbidity and mortality.
Category
  • Kidney Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Updates in the Management of Gastrointestinal Stromal Tumors
The diagnosis and treatment of gastrointestinal stromal tumors (GISTs) has undergone significant modification within recent years. Continued education for oncology care providers is necessary to convey updates in the management of GISTs and improve patient outcomes.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Update: Triple Negative Breast Cancer
By staying up-to-date on new approaches and options for systemic therapies (neoadjuvant/adjuvant and metastatic disease), clinicians should be able to provide appropriate care using a shared decision-making process with the patient.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Challenging Case Review: Colorectal Cancer
As a result of the therapeutic advances and clinical research affecting the management of patients with cancer, clinicians can benefit by comparing their individual skills of diagnosis, treatment, and management of patients with their peers.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Advances in Oncofertility: Fertility Preservation Options for Adolescents and Young Adults with Cancer
Education regarding oncofertility is required to bridge the gap in adolescent and young adults cancer care and improve outcomes in this population.
Category
  • Fertility Preservation
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Supportive Care in Head and Neck Cancers: Multidisciplinary Management
The initial evaluation and development of a plan for treating the patient with head and neck (H&N) cancer requires a multidisciplinary team of health care providers with expertise in caring for these patients. Further, managing and preventing sequelae after surgery, radiation therapy, and systemic therapy requires professionals familiar with H&N cancer.
Category
  • Head and Neck Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Settings for Immune Checkpoint Inhibitors in Urothelial Bladder Cancer
With many new indications for immune checkpoint inhibitors in urothelial bladder cancer, as well as a number of important ongoing trials using these agents, timely education on this topic is important.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Update: Multiple Myeloma
Clinicians must understand the evolving therapeutic options and guidelines for administration of the available therapies in the context of the patient's therapeutic and disease history to navigate through the complex treatment landscape.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Uterine Cancers
Uterine sarcomas and carcinosarcomas vary in presentation, but are generally aggressive tumors with a poor prognosis; therefore, accurate diagnosis of these tumor types is critical. Biomarker testing/molecular profiling may be used in combination with histopathological assessment to improve diagnosis, determine prognosis, and optimize treatment selection.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Treatment of Locally Advanced Colorectal Cancer
Trimodal therapy approaches for localized rectal cancer continue to evolve as new data helps define how to best improve outcomes while reducing adverse effects, with total neoadjuvant therapy (TNT) among the approaches of recent interest.  Additionally, new therapies have substantially expanded the treatment options for mCRC in recent years.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages